Arcus Biosciences

Arcus Biosciences

Quarterly Financials

Values in thousands2026-06-302026-03-312025-12-312025-09-30
Revenue
$41,000
$17,000
$33,000
$26,000
Gross Profit
41,000
15,000
30,000
24,000
EBITDA
-85,000
-123,000
-81,000
-130,000
EBIT
-88,000
-125,000
-84,000
-132,000
Net Income
-91,000
-128,000
-98,000
-135,000
Net Change In Cash
41,000
17,000
33,000
26,000
Free Cash Flow
-119,000
-138,000
-121,000
-97,000
Cash
150,000
201,000
222,000
238,000
Basic Shares
126,100
125,400
107,400
106,500

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$247,000
$258,000
$117,000
$112,000
Gross Profit
237,000
258,000
117,000
112,000
EBITDA
-335,000
-269,000
-291,000
-258,000
EBIT
-345,000
-279,000
-299,000
-264,000
Net Income
-353,000
-283,000
-307,000
-267,000
Net Change In Cash
247,000
258,000
117,000
112,000
Free Cash Flow
-484,000
-176,000
-330,000
432,000
Cash
222,000
150,000
127,000
206,000
Basic Shares
107,400
90,100
74,000
72,000

Earnings Calls

QuarterEPS
2026-06-30
-$0.72
2026-03-31
-$1.02
2025-12-31
-$0.89
2025-09-30
-$1.27